Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1X1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,874
Award facts
- Contract value 100% obligated
- $38,874.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,874.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Cencora, Inc.) on February 3, 2026, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion deadline of February 4, 2026. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999 and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement.
Mounjaro (tirzepatide) is a GLP-1 receptor agonist used for diabetes treatment, aligning with AmerisourceBergen's extensive portfolio of specialty medications supplied to military healthcare systems, veterans' facilities, and other federal agencies. The order exemplifies the company's role as a pharmaceutical prime vendor supporting the Defense Health Agency and broader military healthcare operations. AmerisourceBergen's DLA Troop Support contract serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic drugs, vaccines, medical supplies, and specialty medications across multiple therapeutic domains to support military treatment facilities and federal health programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FN1X1?
SPE2DR26FN1X1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FN1X1 worth?
The government has obligated $38,874 on SPE2DR26FN1X1.
Is contract SPE2DR26FN1X1 an order under another contract?
Yes. SPE2DR26FN1X1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1X1 competed?
The extent of competition for SPE2DR26FN1X1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award